Regulatory Issues

The Marriage of Technology and Policy

By Yuriy Pylypchuk & Carmen Smiley – When a family member, friend, or loved one develops an opioid addiction, few people know how to respond. Similarly, it is often difficult for healthcare providers to know how to best prevent, detect, and treat opioid use disorder, and almost every provider in the country has had encounters with patients experiencing addiction.

Read More

ONC Announces Synthetic Health Data Challenge Winners

The ONC announced $100,000 in total awards to six winners of the Synthetic Health Data Challenge (Challenge). Synthetic health data (i.e., data that is artificially created to mimic real-world data), is important to researchers, health IT developers, and informaticians, among others, who need data to test new ideas until access to secure and actual clinical data is available.



Medicare Coverage of Innovative Technologies (MCIT)

By Dr. Lee A. Fleisher – CMS is committed to ensuring people on Medicare have quicker access to innovative medical technologies for life-threatening or irreversibly debilitating diseases – like cancer and heart disease. In January 2021, we published a final rule called The Medicare Coverage of Innovative Technology and Definition of ‘Reasonable and Necessary’ (MCIT/R&N).


Moving Ahead on Information Sharing

By Micky Tripathi – The ONC Cures Act Final Rule went into effect on April 5, 2021 and as a result we have seen an increase in both the quantity and complexity of questions regarding the regulations. We’re eager to help the industry successfully implement these new requirements and, even more important…


Monday Morning Rounds with CMS

In case you missed it, this is recent communication from the Centers for Medicare & Medicaid Services. Subscribe to their email lists to keep up to date on all press and news releases.